Alan S. Yu

Alan S. Yu

University of Kansas

H-index: 55

North America-United States

About Alan S. Yu

Alan S. Yu, With an exceptional h-index of 55 and a recent h-index of 36 (since 2020), a distinguished researcher at University of Kansas, specializes in the field of Renal tubule physiology and disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Change in albuminuria and GFR slope as joint surrogate end points for kidney failure: implications for phase 2 clinical trials in CKD

Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease

Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing

The role of claudin-2 in kidney function and dysfunction

Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

A systematic review of reported outcomes in ADPKD studies

Contribution of phosphate and FGF23 to CKD progression

Alan S. Yu Information

University

Position

University of Kansas Medical Center

Citations(all)

11097

Citations(since 2020)

5145

Cited By

7694

hIndex(all)

55

hIndex(since 2020)

36

i10Index(all)

121

i10Index(since 2020)

82

Email

University Profile Page

University of Kansas

Google Scholar

View Google Scholar Profile

Alan S. Yu Skills & Research Interests

Renal tubule physiology and disease

Top articles of Alan S. Yu

Title

Journal

Author(s)

Publication Date

Change in albuminuria and GFR slope as joint surrogate end points for kidney failure: implications for phase 2 clinical trials in CKD

Hiddo JL Heerspink

Lesley A Inker

Hocine Tighiouart

Willem H Collier

Benjamin Haaland

...

2023/6/1

Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease

American Journal of Physiology-Renal Physiology

Eden A Houske

Matthew G Glimm

Annika R Bergstrom

Sally K Slipher

Hope D Welhaven

...

2023/6/1

Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing

The Journal of Clinical Investigation

Rizwan Ahmad

Balawant Kumar

Ishwor Thapa

Raju Lama Tamang

Santosh K Yadav

...

2023/12/1

The role of claudin-2 in kidney function and dysfunction

Duuamene Nyimanu

Christine Behm

Sonali Choudhury

Alan SL Yu

2023/8/31

Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Kyongtae T Bae

Cheng Tao

Robert Feldman

SL Alan

Vicente E Torres

...

2022/3/1

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

American Journal of Physiology-Renal Physiology

Shirin V Sundar

Julie Xia Zhou

Brenda S Magenheimer

Gail A Reif

Darren P Wallace

...

2022/10/1

A systematic review of reported outcomes in ADPKD studies

Sara S Jdiaa

Nedaa M Husainat

Razan Mansour

Mohamad A Kalot

Kerri McGreal

...

2022/9/1

Contribution of phosphate and FGF23 to CKD progression

Kyle P Jansson

SL Alan

Jason R Stubbs

2022/7/1

POS-513 RISK OF COVID-19 DISEASE, DIALYSIS UNIT ATTRIBUTES AND INFECTION CONTROL STRATEGY AMONG LONDON IN-CENTRE HAEMODIALYSIS PATIENTS: A RETROSPECTIVE COHORT STUDY

Kidney International Reports

B Caplin

D Ashby

K Mccafferty

R Hull

E Asgari

...

2021/4/1

Establishing a core outcome set for autosomal dominant polycystic kidney disease: report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD …

American Journal of Kidney Diseases

Yeoungjee Cho

Allison Tong

Jonathan C Craig

Reem A Mustafa

Arlene Chapman

...

2021/2/1

A computable phenotype for autosomal dominant polycystic kidney disease

Kidney360

Mohamad A Kalot

Abdallah El Alayli

Mohammad Al Khatib

Nedaa Husainat

Kerri McGreal

...

2021/11/1

Pain and obesity in autosomal dominant polycystic kidney disease: a post hoc analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) studies

Kidney Medicine

Kristen L Nowak

Kaleigh Murray

Zhiying You

Berenice Gitomer

Godela Brosnahan

...

2021/7/1

Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern

Communications Biology

Sébastien Tabariès

Matthew G Annis

Anthoula Lazaris

Stephanie K Petrillo

Jennifer Huxham

...

2021/6/2

Proximal Tubule‐Specific Knockout of Claudin‐2 Causes Hypercalciuria in Mice

The FASEB Journal

Christine Behm

Heather Jackson

Stephen Parnell

Alan Yu

2021/5

The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD

JCI insight

Sravanthi Lavu

Lisa E Vaughan

Sarah R Senum

Timothy L Kline

Arlene B Chapman

...

2020/8/8

Global Challenges and Initiatives in Kidney Health

Valerie Luyckx

Boris Bikbov

Aminu Bello

Alan SL Yu

Glen M Chertow

...

2020

Biological efficacy and safety of niacinamide in patients with ADPKD

Kidney international reports

Mireille El Ters

Xia Zhou

Rebecca J Lepping

Pengcheng Lu

Rainer T Karcher

...

2020/8

Developmental Programming of Blood Pressure and Renal Function

Valerie Luyckx

Karen Moritz

John Bertram

Alan SL Yu

Glen M Chertow

...

2020

Interactions between FGF23 and genotype in autosomal dominant polycystic kidney disease

Kidney360

Laura Grau

Berenice Gitomer

Bryan McNair

Myles Wolf

Peter Harris

...

2020/7/1

Changing relative risk of clinical factors for hospital-acquired acute kidney injury across age groups: a retrospective cohort study

BMC nephrology

Lijuan Wu

Yong Hu

Xiangzhou Zhang

Weiqi Chen

Alan SL Yu

...

2020/12

See List of Professors in Alan S. Yu University(University of Kansas)